PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, 246 Xuefu Road, Nangang District, Harbin, 150086, China.\', \'The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, 246 Xuefu Road, Nangang District, Harbin, 150086, China.\', \'Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, 246 Xuefu Road, Nangang District, Harbin, 150086, China. tianjinweidr2009@163.com.\', \'The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, 246 Xuefu Road, Nangang District, Harbin, 150086, China. tianjinweidr2009@163.com.\', \'Guangxi Key Laboratory of Diabetic Systems Medicine, Guilin Medical University, Guilin, 541000, Guangxi, China. tianjinweidr2009@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s10557-020-07120-8
?:doi
?:hasPublicationType
?:journal
  • Cardiovascular drugs and therapy
is ?:pmid of
?:pmid
?:pmid
  • 33404925
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.349
?:rankingScore_hIndex
  • 61
is ?:relation_isRelatedTo_publication of
?:title
  • Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all